<DOC>
	<DOCNO>NCT02401269</DOCNO>
	<brief_summary>CVD account 15 % deaths Malawi . Both HIV ART risk factor CVD direct toxic inflammatory cardiovascular effect . ( 44,45 ) . At moment , one every 10 Malawian HIV positive roughly 8 10 infected ART ( 2 ) . Therefore , HIV ART may contribute burden CVD Malawi . Currently , study assess CVD risk HIV patient population ART . In Malawi , study exist . Therefore , investigator propose novel study assess baseline cardiovascular disease risk use two novel ultrasound technology HIV patient ART . Cardiovascular disease risk assess use surrogate cardiovascular marker disease . These surrogate include marker endothelial function cardiovascular modulate inflammatory biomarkers . The inflammatory biomarkers measure TNF-alpha , IL-6 , CRP . Aspirin , way antiplatelet anti-inflammatory effect demonstrate inhibit atherosclerosis way decrease TNF-alpha , IL-6 , CRP improve endothelial function . Therefore second aim study demonstrate aspirin improve surrogate marker atherosclerosis .</brief_summary>
	<brief_title>Cardiovascular Risk HIV Patients Antiretroviral Therapy Therapy : The MHEART Study</brief_title>
	<detailed_description>To address objective design six-month prospective randomize control study ( RCT ) investigate cardiovascular disease risk HIV patient ART implementation aspirin versus placebo strategy investigate whether risk modify . As nearly HIV patient anticipated ART upcoming decade , decide open study virally suppress HIV ART . A total 100 virally suppressed HIV positive Malawians ART enrol study . Initial screen occur patient population identify HIV positive viral load suppression ART last 3 month . The initial screening provide cross-sectional information baseline demographic , clinical , laboratory characteristic virally suppress HIV patient ART ass baseline cardiovascular risk use laboratory biomarker data endothelial function surrogate marker ( see section procedure ) . Ability distal artery dilate stress measure use novel ultrasound technology applicable limited resource healthcare setting Malawi . After initial screening , eligibility study determine select participant randomize one two arm : 1 . Oral aspirin 325mg daily 2 . Oral placebo daily . This longitudinal RCT reassess cardiovascular risk one-month , 3-month , six-month mark use CVD surrogate measurement atherosclerosis perform initial screening . Procedures assess surrogate CVD marker atherosclerosis : 1 . Laboratory analysis ( Venipuncture ) : Inflammatory biomarkers â€¢ C-Reactive Protein ( CRP ) , Interleukin-6 , Tumor Necrosis Factor- alpha 2 . Endo-PAT analysis 3 . Brachial Flow Mediated dilation 4 . Carotid Intima-Media Thickness</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Malawian men woman age 1870 HIV positive ART least 6 month standard therapy ( 1st line , 2nd line 3rd line ) . The HIV viral load time enrollment must suppress confirm HIV DNA PCR last 60 day . All patient risk factor result endothelial dysfunction atherosclerosis exclude base follow exclusion criterion . The rationale behind isolate effect virally suppress HIV endothelial activity . 1 . Presence HIV viral load last 60 day 2 . History diagnose Diabetes Mellitus 3 . Fasting blood sugar &gt; 110 time enrollment determine glucose chemistry profile 4 . Uncontrolled Hypertension define systolic blood pressure &gt; equal 140 diastolic &gt; 100 mmHg time enrollment 5 . AST ALT &gt; 200 within last 30 day . If obtain interval , baseline AST/ALT obtain 6 . Renal Failure time recruitment ( Gfr . &lt; 60ml/min/1.73 ) base Cockcroft Gault equation . 7 . History myocardial infarction , peripheral vascular disease , cerebrovascular disease . These also assess clinically time enrollment 8 . Health condition would place patient health risk perfusion ischemia EndoPAT , FMD , CIMT measurement . 9 . Current tobacco use history tobacco use last 90 day 10 . Platelet count le 100 time enrollment 11 . History active brain mass/lesion 12 . Gastrointestinal bleeding last 12 month 13 . History hemorrhagic stroke 14 . Major life threaten bleed last 12 month 15 . Patients consider high bleed risk base physician assessment 16 . History medication noncompliance last 3 month 17 . Pregnancy 18 . Contraindications aspirin Previous allergic reaction aspirin similar medication aspirin Asthma nasal congestion nasal polyp Bleeding disorder ( inherit acquire ) Chicken pox</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>